Bowel Resection: What the Data Really Shows

Whether surgery is planned for colorectal cancer or a benign condition such as diverticular disease or Crohn's disease, patients and referring clinicians rightly want to understand what outcomes look like in practice — not just in principle. This article sets out the evidence base for bowel resection, explains the metrics that matter most, and places my own audited results alongside national benchmarks.

What Is a Bowel Resection?

A bowel resection is the surgical removal of a segment of the large intestine (colon or rectum). It is performed for a range of conditions: colorectal cancer is the most common indication, but resections are also undertaken for diverticular disease, Crohn's disease, ulcerative colitis, volvulus, and large polyps that cannot be removed endoscopically.

In the majority of cases the cut ends of bowel are rejoined — a join called an anastomosis. Occasionally a temporary or permanent stoma is required, though minimally invasive technique and careful patient selection significantly reduce this risk in elective cases.

Cancer Resection: The Oncological Imperative

For colorectal cancer, surgical resection with adequate oncological margins remains the cornerstone of curative treatment. The key technical goals are a clear circumferential resection margin (CRM), adequate lymph node harvest, and — for rectal cancer — preservation of the mesorectal envelope via total mesorectal excision (TME).

What outcomes data tells us

The National Bowel Cancer Audit (NBOCA) publishes annual outcomes across all NHS trusts in England and Wales. Key population-level benchmarks include:

One of the most trusted and successful colorectal surgeons in the Midlands — with outcomes data to prove it.

▶ Watch Mr Papettas discuss his practice and approach

"The anastomotic leak rate is arguably the single most important quality indicator in bowel resection surgery. It determines not only immediate morbidity but long-term oncological outcome and quality of life."

Survival after cancer surgery

Beyond the operative period, 2-year survival after colorectal cancer resection is the outcome patients most want to understand. My audited data show 2-year survival rates above the NBOCA national average — a reflection of oncological case selection, completeness of resection, and the low rate of serious postoperative complications that can compromise subsequent chemotherapy or delay adjuvant treatment.

It is worth noting that survival data must always be interpreted in the context of case mix — surgeons who take on higher-risk, more advanced presentations will, all else being equal, face more challenging survival statistics. My practice encompasses complex and re-operative cases, which makes above-average survival outcomes more meaningful, not less.

Return to theatre and transfusion: markers of operative precision

The rate at which patients require unplanned return to the operating theatre — for bleeding, anastomotic failure, or other early complications — is a direct indicator of operative safety. My return to theatre rate sits below the national average, consistent with the low anastomotic leak rate and a meticulous approach to haemostasis intraoperatively.

Post-operative blood transfusion rates follow the same pattern. Minimally invasive technique inherently reduces intraoperative blood loss compared to open surgery, but transfusion rates also reflect preoperative optimisation — particularly correction of iron deficiency anaemia before elective cases — and careful intraoperative haemostasis. My transfusion rate is below the national average, reducing the risks associated with allogenic blood and supporting faster recovery.

An anastomotic leak — where the join between bowel ends fails to heal — occurs in 3–8% of cases nationally and carries significant consequences: prolonged hospital stay, emergency reoperation, potential permanent stoma, and in oncological cases, evidence that it worsens long-term cancer recurrence rates. Factors reducing leak risk include minimally invasive technique, avoidance of tension, meticulous blood supply assessment, and selective use of defunctioning stoma in high-risk anastomoses.

Benign Resection: A Different Risk-Benefit Calculus

When surgery is for a benign condition, the decision to operate involves a more nuanced judgement — since unlike cancer, the indication is not always urgent. The goal is to relieve symptoms or prevent serious complications (such as perforation or fistula) while minimising operative morbidity.

Diverticular disease

Sigmoid colectomy for recurrent or complicated diverticular disease is one of the most common benign colorectal resections. Laparoscopic sigmoid colectomy has become the standard approach, with benefits including significantly reduced postoperative pain, shorter hospital stay (typically 2–4 days versus 5–7 days open), and faster return to normal activity. Conversion to open surgery — historically 15–25% in population studies — is well below 5% in high-volume minimally invasive practices.

Crohn's disease

Surgical resection in Crohn's disease is typically reserved for stricturing, penetrating, or medically refractory disease. The principal concern is bowel conservation — given the lifelong nature of the condition and the risk of short bowel syndrome with repeated resections. Laparoscopic ileocaecal resection has become the preferred approach at most specialist centres, with recurrence rates influenced more by postoperative medical optimisation than surgical technique per se.

Ulcerative colitis

Total colectomy or restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) represents potentially curative surgery for ulcerative colitis. Pouch surgery — forming a reservoir from the small intestine — requires specialist experience. I am one of a small number of surgeons in the region regularly performing pouch surgery, with outcomes benchmarked to national specialist centre data.

Minimally Invasive, Robotic, and Open Surgery

The shift from open to laparoscopic colorectal resection over the past two decades represents one of the most evidence-supported advances in surgical care. Randomised controlled trial data confirm equivalent oncological outcomes with meaningful reductions in wound complications, blood loss, postoperative ileus, and length of hospital stay.

Robotic-assisted surgery extends these benefits further in complex cases — particularly rectal surgery and reoperative pelvic dissection — offering improved instrument articulation, three-dimensional visualisation, and tremor filtration. I am actively developing my robotic surgical practice at Nuffield Health Warwickshire, working within a programme aligned to national training standards.

Having trained and practised over two decades at some of the UK's busiest colorectal units — including Queen Elizabeth Birmingham and Frimley Park — my experience spans the full technical spectrum: robotic, laparoscopic, and open resection. 95% of my resections are performed by a keyhole method — laparoscopic or robotic — against an NHS average of approximately 75%. This breadth matters. Most surgeons in independent practice concentrate on a narrower range; the ability to move fluidly between approaches means patients with complex anatomy, prior surgery, or high-risk presentations are not routinely referred elsewhere.

My conversion rate from minimally invasive to open surgery — a recognised marker of both technical proficiency and appropriate case selection — is below 5%, against a national figure of 10–20%. A lower conversion rate reflects not only surgical skill but the capacity to safely manage intraoperative difficulty without defaulting to open access.

Trainer of Surgeons

I am an active trainer of surgical registrars within the South Warwickshire NHS Foundation Trust, supervising trainees across colorectal, general, and emergency surgery. Being recognised as a surgical trainer reflects not just technical proficiency but the ability to teach — which requires a deeper, more deliberate understanding of operative anatomy, decision-making, and safe practice than routine independent operating alone demands.

For patients, this has a direct implication: a surgeon who trains others is a surgeon whose technique and judgement are continuously scrutinised, discussed, and refined. The standards expected of a trainer are higher than those expected of a practitioner.

Exclusively Local — By Choice

Many consultants of comparable experience maintain practice across multiple sites or divide their time between regional and London lists. I do not. My private practice is based exclusively at Nuffield Health Warwickshire — a deliberate decision rooted in being a committed family man with strong ties to this community.

For patients, this matters practically. My availability, attention, and continuity of care are not spread thin across geography. The consultant you meet in clinic is the surgeon who operates, and the same surgeon who sees you in follow-up. Relationships with local GPs, the Nuffield nursing teams, and the wider multidisciplinary network are long-standing and direct — not managed at a distance.

This is not a limitation. It is a considered choice about what good surgical practice looks like.

What Should Patients Ask Their Surgeon?

When being assessed for bowel resection, these are the questions most likely to help you evaluate the care being offered:

Surgeons who publish their outcomes data — whether through NBOCA, PHIN, or their own practice — are demonstrating a commitment to transparency that benefits patients directly. I make my audited outcomes available and am happy to discuss them in consultation.

A Note on Enhanced Recovery

Enhanced Recovery After Surgery (ERAS) protocols, now standard across elective colorectal practice, have compressed typical hospital stays considerably. Patients undergoing elective laparoscopic colectomy can now reasonably expect a 2–4 day admission in uncomplicated cases, with return to light activity within 2–3 weeks. Optimisation before surgery — including correction of iron deficiency anaemia, nutritional support, and smoking cessation — is increasingly recognised as a determinant of outcome that sits outside the operating theatre.

This article is written for informational purposes and does not constitute individual medical advice. All outcome data are drawn from the author's own audited practice and published national benchmarks (NBOCA). Figures are correct as of the date of publication. Patients should discuss their individual circumstances with a qualified surgeon.